Results 11 to 20 of about 63,195 (230)

Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy

open access: yesESC Heart Failure, 2021
Aims In Fabry cardiomyopathy, left ventricular outflow tract obstruction mimicking hypertrophic cardiomyopathy is a very rare finding, with few cases reported and successfully treated with cardiac surgery. In our population of patients with Fabry disease
Francesca Graziani   +10 more
doaj   +1 more source

Mid-ventricular Obstructive Cardiomyopathy after Takotsubo Cardiomyopathy

open access: yesInternal Medicine, 2023
A 93-year-old woman was transferred to our hospital for lightheadedness. She had had Takotsubo cardiomyopathy for seven years. Transthoracic apical four-chamber echocardiography showed a large apical aneurysm. Pulsed-wave Doppler echocardiography at the left ventricular (LV) basal obstruction showed flow directed from the apex to the base during ...
Tabira, Akihisa   +6 more
openaire   +2 more sources

Autosomal Dominant Polycystic Kidney Patients May Be Predisposed to Various Cardiomyopathies

open access: yesKidney International Reports, 2017
Mutations in PKD1 and PKD2 cause autosomal dominant polycystic kidney disease (ADPKD). Experimental evidence suggests an important role of the polycystins in cardiac development and myocardial function.
Fouad T. Chebib   +10 more
doaj   +1 more source

Lack of reliable clinical predictors to identify obstructive sleep apnea in patients with hypertrophic cardiomyopathy

open access: yesClinics, 2013
OBJECTIVE: Obstructive sleep apnea is common among patients with hypertrophic cardiomyopathy and may contribute to poor cardiovascular outcomes. However, obstructive sleep apnea is largely unrecognized in this population.
Flávia B. Nerbass   +6 more
doaj   +1 more source

Treatment of cardiomyopathy with PAP therapy in a patient with severe obstructive sleep apnea. [PDF]

open access: yes, 2012
Obstructive sleep apnea is common in patients with heart failure. This case illustrates that treatment with PAP therapy can improve cardiac function in patients with both conditions.
Grewal, MD, Ritu G.
core   +2 more sources

Symptomatic Obstructive Hypertrophic Cardiomyopathy [PDF]

open access: yesCirculation: Cardiovascular Interventions, 2013
Hypertrophic cardiomyopathy (HCM) is a common, yet challenging condition for clinical management. The majority of these patients have evidence of left ventricular outflow tract (LVOT) obstruction that may be asymptomatic or associated with debilitating symptoms of heart failure.
Paul, Sorajja   +2 more
openaire   +2 more sources

Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy

open access: yesJournal of Veterinary Internal Medicine, 2020
Background N‐terminal pro B‐type natriuretic peptide (NT‐proBNP) and cardiac troponin‐I (cTnI) are biomarkers commonly evaluated in cats with suspected heart disease.
Joonbum Seo   +5 more
doaj   +1 more source

Left ventricular myocardial strain and electrocardiographic changes in children with hypertrophic cardiomyopathy

open access: yesМедицинский совет, 2021
Introduction. Hypertrophic cardiomyopathy is one of the most common diseases of the myocardium in children. Meanwhile, the relationship between indicators of strain and electrocardiographic changes, their diagnostic significance for children with ...
N. Yu. Chernykh   +3 more
doaj   +1 more source

Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy [PDF]

open access: yes, 2019
BackgroundPulmonary hypertension (PH) is a known complication of HCM and is a strong predictor of mortality. We aim to investigate the relationship between microvascular dysfunction measured by quantitative PET and PH in HCM patients.MethodsEighty-nine ...
Leal, Jeffrey P   +6 more
core   +3 more sources

Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy. [PDF]

open access: yes, 2014
Contraction in the mammalian heart is controlled by the intracellular Ca2+ concentration as it is in all striated muscle, but the heart has an additional signalling system that comes into play to increase heart rate and cardiac output during exercise or ...
Marston, SB, Messer, AE
core   +2 more sources

Home - About - Disclaimer - Privacy